| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $290.1M | +28.6% |
| Cost of Revenue | $66.2M | +3.3% |
| Gross Profit | $223.9M | +38.6% |
| R&D Expense | $49.2M | +50.8% |
| SG&A Expense | $57.7M | +11.4% |
| Operating Income | $24.0M | +1560.8% |
| Pre-tax Income | -$16.0M | +40.9% |
| Income Tax | -$9.6M | -265.5% |
| Net Income | -$6.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $210.2M | +154.5% |
| Accounts Receivable | $61.8M | -7.6% |
| Current Assets | $286.5M | +80.9% |
| Total Assets | $378.3M | +58.5% |
| Current Liabilities | $68.5M | -55.9% |
| Total Liabilities | $72.6M | -59.1% |
| Stockholders' Equity | $305.7M | +384.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $56.5M | +32.7% |
| Investing Cash Flow | -$17.1M | -72.0% |
| Financing Cash Flow | $88.2M | +1863.1% |
| +80.5% |
| EPS (Basic) | -$0.13 | +94.5% |
| EPS (Diluted) | -$0.13 | +94.5% |